RxDoctor Payments Data

Timothy Heston, DO

Family Medicine · Topeka, KSNPI 1699889014

Payments from drug & device makers

$408in general payments, 2019–2025

Across 22 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$91
  • AbbVie$80
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$63
  • Teva Pharmaceuticals USA, Inc.$40
  • Novartis$37
  • Avanir Pharmaceuticals, Inc.$27
  • plus $70 from 4 others

What the payments were for

  • Food & beverage$408100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$408 in reported general payments places this provider in the 45th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$473,904
Medicare patients
562
Services billed
5,574

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate122$416,467
EliquisApixaban787$243,989
Austedo XrDeutetrabenazine49$219,146
AustedoDeutetrabenazine57$177,396
RebifInterferon Beta-1a/Albumin13$145,676
MyrbetriqMirabegron586$128,263
EnbrelEtanercept13$91,492
TrulicityDulaglutide84$86,010
Risperdal ConstaRisperidone Microspheres39$71,747
JardianceEmpagliflozin217$63,680
NuplazidPimavanserin Tartrate18$51,688
LybalviOlanzapine/Samidorphan Malate28$48,214
JanuviaSitagliptin Phosphate157$46,908
VraylarCariprazine Hcl68$45,816
XareltoRivaroxaban110$39,961

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta, Xarelto$14$528,175271 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr, Austedo$40$396,542106 claims
AbbVieVraylar, Creon, Linzess$80$108,388148 claims
Alkermes, Inc.Lybalvi$91$48,21428 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Topeka

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →